COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn BHBH FPVFPV FLVFLV PVP-IPI REGNR2 LY-CoVLY RMDRMD
Remdesivir study #1 of 16
4/10 Late treatment study
Grein et al., NEJM, doi:10.1056/NEJMoa2007016 (Peer Reviewed)
Compassionate Use of Remdesivir for Patients with Severe Covid-19
Source   PDF   Share   Tweet
Report on compassionate use of remdesivir with 61 severe COVID-19 patients, showing clinical improvement in 36 of 53 patients.

Grein et al., 4/10/2020, peer-reviewed, 59 authors.
Details of all 16 studies
Please send us corrections, updates, or comments.